Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pulmonary Sarcoidosis: Experimental Models and Perspectives of Molecular Diagnostics Using Quantum Dots. | Int J Mol Sci | 2023 | 37511027 | PubTator, text mining | PubMed |
| Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma. | Biology (Basel) | 2023 | 37508413 | PubTator, text mining | PubMed |
| PreCanCell: An ensemble learning algorithm for predicting cancer and non-cancer cells from single-cell transcriptomes. | Comput Struct Biotechnol J | 2023 | 37501705 | PubTator, text mining | PubMed |
| Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma. | Front Immunol | 2023 | 37497213 | PubTator, text mining | PubMed |
| Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1. | J Biol Chem | 2023 | 37495108 | PubTator, text mining | PubMed |
| Multi-tiered approach to detect autoimmune cross-reactivity of therapeutic T cell receptors. | Sci Adv | 2023 | 37494434 | PubTator, text mining | PubMed |
| The minichromosome maintenance complex drives esophageal basal zone hyperplasia. | JCI Insight | 2023 | 37490338 | PubTator, text mining | PubMed |
| A survey of artificial intelligence in rheumatoid arthritis. | Rheumatol Immunol Res | 2023 | 37485476 | PubTator, text mining | PubMed |
| Novel target and treatment agents for natural killer/T-cell lymphoma. | J Hematol Oncol | 2023 | 37480137 | PubTator, text mining | PubMed |
| A multi-mineral intervention to counter pro-inflammatory activity and to improve the barrier in human colon organoids. | Front Cell Dev Biol | 2023 | 37476158 | PubTator, text mining | PubMed |
| Defining critical illness using immunological endotypes in patients with and without sepsis: a cohort study. | Crit Care | 2023 | 37474944 | PubTator, text mining | PubMed |
| Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System. | Infect Drug Resist | 2023 | 37465179 | PubTator, text mining | PubMed |
| Targeting endometrial inflammation in intrauterine adhesion ameliorates endometrial fibrosis by priming MSCs to secrete C1INH. | iScience | 2023 | 37456855 | PubTator, text mining | PubMed |
| Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives. | Int J Mol Sci | 2023 | 37445907 | PubTator, text mining | PubMed |
| Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome. | Int J Mol Sci | 2023 | 37445688 | PubTator, text mining | PubMed |
| The Clinical Characteristics and Outcomes of Human Papillomavirus-Positive Nasopharyngeal Carcinoma in a Single-Institution Cohort. | J Clin Med | 2023 | 37445299 | PubTator, text mining | PubMed |
| Genetic control of the dynamic transcriptional response to immune stimuli and glucocorticoids at single-cell resolution. | Genome Res | 2023 | 37442575 | PubTator, text mining | PubMed |
| EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion. | Mol Metab | 2023 | 37442376 | PubTator, text mining | PubMed |
| p16INK4a and pRb expression in laryngeal squamous cell carcinoma with and without infection by EBV or different genotypes of HPV: a retrospective study. | Infect Agent Cancer | 2023 | 37434200 | PubTator, text mining | PubMed |
| Deep learning identifies a T-cell exhaustion-dependent transcriptional signature for predicting clinical outcomes and response to immune checkpoint blockade. | Oncogenesis | 2023 | 37433793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=16